444 related articles for article (PubMed ID: 23129632)
1. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
Luo W; Chang R; Zhong J; Pandey A; Semenza GL
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):E3367-76. PubMed ID: 23129632
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of Jumonji domain containing protein 2C and hypoxia-inducible factor-1α in gastric carcinoma and their clinical significance].
Xu Y; Yao HB; Jin Y; Ma YY; Wang HJ; Shao QS
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3375-8. PubMed ID: 24418035
[TBL] [Abstract][Full Text] [Related]
3. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Guo X; Tian Z; Wang X; Pan S; Huang W; Shen Y; Gui Y; Duan X; Cai Z
Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):106-13. PubMed ID: 25520177
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Xiang L; Gilkes DM; Hu H; Luo W; Bullen JW; Liang H; Semenza GL
Oncotarget; 2015 May; 6(14):11768-78. PubMed ID: 26059435
[TBL] [Abstract][Full Text] [Related]
5. Jumonji domain containing 2C promotes cell migration and invasion through modulating CUL4A expression in lung cancer.
Li N; Jiang D
Biomed Pharmacother; 2017 May; 89():305-315. PubMed ID: 28236704
[TBL] [Abstract][Full Text] [Related]
6. Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene.
Ishimura A; Terashima M; Kimura H; Akagi K; Suzuki Y; Sugano S; Suzuki T
Biochem Biophys Res Commun; 2009 Nov; 389(2):366-71. PubMed ID: 19732750
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
8. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.
Beyer S; Kristensen MM; Jensen KS; Johansen JV; Staller P
J Biol Chem; 2008 Dec; 283(52):36542-52. PubMed ID: 18984585
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer.
Hong Q; Yu S; Yang Y; Liu G; Shao Z
Oncotarget; 2014 Jul; 5(13):4779-87. PubMed ID: 24952432
[TBL] [Abstract][Full Text] [Related]
10. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis.
Yang D; Xu T; Fan L; Liu K; Li G
J Exp Clin Cancer Res; 2020 Sep; 39(1):201. PubMed ID: 32972441
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
Peng K; Zhuo M; Li M; Chen Q; Mo P; Yu C
Oncogene; 2020 Nov; 39(47):7076-7091. PubMed ID: 32989255
[TBL] [Abstract][Full Text] [Related]
12. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha.
Pollard PJ; Loenarz C; Mole DR; McDonough MA; Gleadle JM; Schofield CJ; Ratcliffe PJ
Biochem J; 2008 Dec; 416(3):387-94. PubMed ID: 18713068
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase JMJD2C: epigenetic regulators in tumors.
Zhang C; Wang Z; Ji Q; Li Q
Oncotarget; 2017 Oct; 8(53):91723-91733. PubMed ID: 29207681
[TBL] [Abstract][Full Text] [Related]
15. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
Chen Y; Zhang B; Bao L; Jin L; Yang M; Peng Y; Kumar A; Wang JE; Wang C; Zou X; Xing C; Wang Y; Luo W
J Clin Invest; 2018 May; 128(5):1937-1955. PubMed ID: 29629903
[TBL] [Abstract][Full Text] [Related]
16. CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
Li ZF; Meng DD; Liu YY; Bi FG; Tian K; Xu JZ; Sun JG; Gu CX; Li Y
Chem Biol Interact; 2022 Jan; 351():109759. PubMed ID: 34826399
[TBL] [Abstract][Full Text] [Related]
18. KDM4A regulates HIF-1 levels through H3K9me3.
Dobrynin G; McAllister TE; Leszczynska KB; Ramachandran S; Krieg AJ; Kawamura A; Hammond EM
Sci Rep; 2017 Sep; 7(1):11094. PubMed ID: 28894274
[TBL] [Abstract][Full Text] [Related]
19. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.
Zhang H; Lu H; Xiang L; Bullen JW; Zhang C; Samanta D; Gilkes DM; He J; Semenza GL
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6215-23. PubMed ID: 26512116
[TBL] [Abstract][Full Text] [Related]
20. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.
Yang J; Jubb AM; Pike L; Buffa FM; Turley H; Baban D; Leek R; Gatter KC; Ragoussis J; Harris AL
Cancer Res; 2010 Aug; 70(16):6456-66. PubMed ID: 20682797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
